"Ό,τι η ψυχή επιθυμεί, αυτό και πιστεύει." Δημοσθένης (Whatever the soul wishes, thats what it believes, Demosthenes)
Showing posts with label Vaccine. Show all posts
Showing posts with label Vaccine. Show all posts
Monday, April 13, 2020
COVID-19: What we must do to prevent a global depression
Klaus Schwab Founder and Executive Chairman, World Economic Forum
12-15 minutes
No diagrams & photos, original in the link.
Without a vaccine or effective COVID-19 treatment, we could face continued infections and death until at least the end of 2020.
To prevent further spread of coronavirus, we must monitor what fraction of the population has been in contact with the virus and is potentially immune.
To prevent an economic collapse, governments will need to take on large and unprecedented roles in securing business continuity and jobs.
A few months in, it is still hard to grasp the scale and scope of COVID-19’s global impact. A third of the world population is under some sort of “lockdown.” Over 200 countries are affected, and the number of new cases and deaths in many places are still growing exponentially. All the while, a second crisis, in the form of an economic recession, is underway.
Sunday, April 12, 2020
The COVID-19 vaccine development landscape
Stephen Mayhew
10-13 minutes
(Figures and Tables ommited, for full article go here)
The genetic sequence of SARS-CoV-2, the coronavirus that causes COVID-19, was published on 11 January 2020, triggering intense global R&D activity to develop a vaccine against the disease. The scale of the humanitarian and economic impact of the COVID-19 pandemic is driving evaluation of next-generation vaccine technology platforms through novel paradigms to accelerate development, and the first COVID-19 vaccine candidate entered human clinical testing with unprecedented rapidity on 16 March 2020.
10-13 minutes
(Figures and Tables ommited, for full article go here)
The genetic sequence of SARS-CoV-2, the coronavirus that causes COVID-19, was published on 11 January 2020, triggering intense global R&D activity to develop a vaccine against the disease. The scale of the humanitarian and economic impact of the COVID-19 pandemic is driving evaluation of next-generation vaccine technology platforms through novel paradigms to accelerate development, and the first COVID-19 vaccine candidate entered human clinical testing with unprecedented rapidity on 16 March 2020.
Subscribe to:
Posts (Atom)